Clinical and Microbial Efficacy of ISV403 in Bacterial Conjunctivitis

PHASE2CompletedINTERVENTIONAL

Enrollment

270

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions

Bacterial Conjunctivitis

Interventions

DRUG

ISV-403

0.6% TID, 5 days

DRUG

Vehicle

Vehicle of ISV-403 TID, 5 days

All Listed Sponsors

lead

Bausch & Lomb Incorporated

INDUSTRY

NCT00622908 - Clinical and Microbial Efficacy of ISV403 in Bacterial Conjunctivitis | Biotech Hunter | Biotech Hunter